Eupraxia Pharmaceuticals Inc.
EPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001581178
No open-market purchases or sales by Eupraxia Pharmaceuticals Inc. insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $163.6M in total; no superinvestor holds it.
Holders of 5% or more of EPRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Eupraxia Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Freedman Joseph S. | 13D/A | 9.00%5.84M shares | −1.20 ppfrom 10.20% | Sep 26, 20252 filings | Mar 16, 2026 | SEC |
| Beutel, Goodman & Co Ltd. | 13G | 8.00%4.06M shares | New | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| Disbrow Robert | 13G/A | 7.00%3.57M shares | – | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
8 Schedule 13D and 13G filings on Eupraxia Pharmaceuticals Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 20261:03 PM ET | Manchester Management Co LLCand 4 others | 13G/A | 4.50%2.77M shares | −3.20 ppfrom 7.70%Below 5% | Jun 30, 2026 | SEC |
| May 12, 20267:04 PM ET | Manchester Management Co LLCand 4 others | 13G/A | 7.70%4.02M shares | −1.50 ppfrom 9.20% | Mar 31, 2026 | SEC |
| Mar 16, 20269:56 PM ET | Freedman Joseph S. | 13D/A | 9.00%5.84M shares | −1.20 ppfrom 10.20% | Mar 13, 2026 | SEC |
| Feb 17, 202611:09 AM ET | Manchester Management Co LLCand 4 others | 13G/A | 9.20%4.90M shares | −1.70 ppfrom 10.90% | Dec 31, 2025 | SEC |
| Nov 14, 20254:37 PM ET | Disbrow Robert | 13G/A | 7.00%3.57M shares | – | Sep 30, 2025 | SEC |
| Nov 14, 20259:10 AM ET | Beutel, Goodman & Co Ltd. | 13G | 8.00%4.06M shares | New | Sep 30, 2025 | SEC |
| Nov 13, 202512:14 PM ET | Manchester Management Co LLCand 4 others | 13G | 10.90%5.84M shares | New | Dec 31, 2024 | SEC |
| Sep 26, 20259:19 PM ET | Freedman Joseph S. | 13D/A | 10.20%5.53M shares | – | Sep 24, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Eupraxia Pharmaceuticals Inc. shares.
No Form 144 notices for Eupraxia Pharmaceuticals Inc. are on file.